Astellas Pharma Inc (TSE:4503)
円 2,196.5 +45.5 (+2.12%) Market Cap: 3.94 Tn Enterprise Value: 4.21 Tn PE Ratio: 13.54 PB Ratio: 2.15 GF Score: 82/100

Q2 2023 Astellas Pharma Inc Earnings Presentation Transcript

Oct 31, 2022 / 07:00AM GMT
Release Date Price: 円2046.5 (+0.91%)

Oct 31, 2022 / 07:00AM GMT
Presentation
Oct 31, 2022 / 07:00AM GMT

=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Chairman of the Board
* Minoru Kikuoka
Astellas Pharma Inc. - CFO & Senior Managing Executive Officer
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division - Senior Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot